Abstract
The purpose of this study is to analyze the financial performance of pharmaceutical companies before and during the covid-19 pandemic. This analysis uses liquidity ratios, profitability ratios, leverage methods with a comparative approach, because the data used are in the form of numbers and conduct analysis using statistics with SPSS instruments. This study used 10 pharmaceutical companies listed on the Indonesia Stock Exchange from 2018 to 2021 using the purposive sampling method. The test methods used are descriptive statistics and paired sample t-tests. The test results showed that there were significant differences in the profitability and growth ratios of pharmaceutical companies before and during the covid-19 pandemic, while liquidity ratios, leverage ratios, activity ratios, firm size and analysis showed insignificant differences in pharmaceutical companies before and during the covid-19 pandemic.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
